» Authors » Ruirui Ji

Ruirui Ji

Explore the profile of Ruirui Ji including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 799
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ji R, Geng Y, Quan X
Sci Rep . 2024 Sep; 14(1):21342. PMID: 39266676
Inferring gene regulatory networks through deep learning and causal inference methods is a crucial task in the field of computational biology and bioinformatics. This study presents a novel approach that...
2.
Ji R, Yan M, Zhao M, Geng Y
Biosystems . 2024 Jul; 243:105279. PMID: 39053644
The pan-cancer initiative aims to study the origin patterns of cancer cell, the processes of carcinogenesis, and the signaling pathways from a perspective that spans across different types of cancer....
3.
Fan R, Ji R, Zou W, Wang G, Wang H, Penney D, et al.
Exp Ther Med . 2016 Oct; 12(4):2435-2438. PMID: 27698745
Andersen-Tawil syndrome (ATS) is an autosomal dominant, multisystem channelopathy characterized by periodic paralysis, ventricular arrhythmias and distinctive dysmorphic facial or skeletal features. The disorder displays marked intrafamilial variability and incomplete...
4.
Wang G, Fan R, Ji R, Zou W, Penny D, Varghese N, et al.
BMC Pulm Med . 2016 Jan; 16:17. PMID: 26801773
Background: Pulmonary arterial hypertension (PAH) is a rare, progressive, fatal vascular disorder. Genetic predisposition plays vital roles in the development of PAH, with most mutations being identified in genes involved...
5.
Wang G, Knight L, Ji R, Lawrence P, Kanaan U, Li L, et al.
Int J Cardiol . 2014 Sep; 177(3):e167-9. PMID: 25189502
No abstract available.
6.
Wang H, Ji R, Meng J, Cui Q, Zou W, Li L, et al.
PLoS One . 2014 Sep; 9(9):e106703. PMID: 25187962
Pulmonary arterial hypertension (PAH) is a devastating disease characterized by abnormal remodeling of small, peripheral pulmonary arteries. Germline mutations in the bone morphogenetic protein receptor type 2 (BMPR2) gene are...
7.
Lee C, Georgiou D, Dagnino-Acosta A, Xu J, Ismailov I, Knoblauch M, et al.
J Biol Chem . 2014 Jul; 289(37):25556-70. PMID: 25053409
Rapamycin at high doses (2-10 mg/kg body weight) inhibits mammalian target of rapamycin complex 1 (mTORC1) and protein synthesis in mice. In contrast, low doses of rapamycin (10 μg/kg) increase...
8.
Collins A, Gupte A, Ji R, Ramirez M, Minze L, Liu J, et al.
Arterioscler Thromb Vasc Biol . 2012 Oct; 32(12):2839-46. PMID: 23023374
Objective: To determine the impact of hematopoietic deletion of nuclear factor- (erythroid-derived 2) like 2 factor (Nrf2) on the development of atherosclerosis and liver injury in an obese, hypercholesterolemic mouse...
9.
Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, et al.
Am J Pathol . 2007 May; 170(6):1831-40. PMID: 17525252
MicroRNAs (miRNAs) are a recently discovered class of endogenous, small, noncoding RNAs that regulate gene expression. Although miRNAs are highly expressed in the heart, their roles in heart diseases are...
10.
Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, et al.
Circ Res . 2007 May; 100(11):1579-88. PMID: 17478730
MicroRNAs (miRNAs) are a recently discovered class of endogenous, small, noncoding RNAs that regulate about 30% of the encoding genes of the human genome. However, the role of miRNAs in...